कंपनी का अवलोकन
Kewaunee Scientific Corporation is a specialized manufacturer that designs, produces, and installs essential laboratory, healthcare, and technical furniture along with related infrastructure products for various clients. The enterprise operates within the Consumer Cyclical sector, specifically categorized under the Furnishings, Fixtures & Appliances industry, which implies its performance is closely tied to broader economic cycles and capital expenditure spending by research institutions. The company's market capitalization stands at $97.74M, supported by an annualized revenue of $287.75M and an organizational workforce comprising 1239 employees. These valuation and revenue figures indicate that the corporation maintains a modest market presence relative to large-cap industrial peers, suggesting a niche position focused on specialized industrial goods rather than mass-market consumer demand.
वित्तीय स्वास्थ्य
The company reported a trailing twelve-month revenue of $287.75M and generated a net income of $11.08M, while its EBITDA reached $26.02M, highlighting a significant disparity between top-line growth and bottom-line profitability that points to substantial operating costs or non-operating expenses. The business generated $15.47M in free cash flow, which provides a tangible measure of financial flexibility allowing the firm to service its obligations, maintain capital expenditures, or return capital without relying solely on external financing. Profitability analysis reveals a gross margin of 28.9%, an operating margin of 3.7%, and a net profit margin of 3.9%, indicating that for every dollar of sales, only a small fraction converts to operating profit before the impact of interest and taxes. The firm holds $8.15M in cash assets against a total debt load of $59.34M, resulting in a debt-to-equity ratio of 81.82, which characterizes the balance sheet as highly leveraged rather than conservative. Despite the high leverage, the current ratio stands at 2.12, demonstrating that the company possesses more than double the current assets required to cover its short-term liabilities, suggesting adequate immediate liquidity. Return on equity is calculated at 17.4% while return on assets sits at 6.8%, revealing that the company effectively utilizes shareholder equity to generate returns but faces lower efficiency when considering the total asset base.
मूल्यांकन आकलन
The stock trades with a trailing P/E ratio of 9.17 and a forward P/E ratio of 15.79, indicating that the market expects a recovery in earnings performance that is not reflected in current profitability but is priced into future expectations. The price-to-book ratio is recorded at 1.38, suggesting that the market values the company's equity at a slight premium above its book value, reflecting intangible assets or growth potential despite current earnings struggles. Alternative valuation metrics such as a price-to-sales ratio of 0.34 and an EV/EBITDA of 5.79 suggest the company is valued at a discount relative to its sales and earnings power, often seen in cyclical industrial sectors facing temporary headwinds. In terms of trading range, the 52-week high is $60.89 and the low is $30.33; without a real-time price, the valuation context relies on these historical bounds to establish volatility and support levels. The stock exhibits a beta of 0.67, meaning its price volatility is significantly lower than the broader market, offering a degree of stability that may appeal to risk-averse investors seeking defensive exposure within the industrial space.
Growth & Income
Revenue growth over the last year is 3.3%, whereas earnings growth is -48.9%, indicating that profitability is declining much faster than revenue expansion, which often signals rising input costs or margin compression that management must address to restore earnings power. The company does not distribute dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which means the firm retains all net income to reinvest into operations, debt reduction, or strategic acquisitions rather than providing income to shareholders. This reinvestment strategy is typical for companies in the early recovery phase or those prioritizing balance sheet strengthening over immediate shareholder returns. Overall, the growth and income profile presents a low-yield, capital-retention strategy where investors are compensated primarily through potential future earnings recovery rather than current cash distributions or significant revenue acceleration.